We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Mark Day, Ph.D. is a director and the president and chief executive officer at Bioasis. Dr. Day also serves as adjunct associate professor at Yale University. Dr. Day has more than 20 years of industry experience and has published more than 60 peer-reviewed manuscripts on translational medicine, impulsivity, stroke, cognitive dysfunction in neurological and psychiatric illness such as Alzheimer’s diseases and ADHD, including first authorships in Nature, Science, Nature Neuroscience, Neuroimaging, Proceedings of the Royal Society. Dr. Day is also a member of the Aeromics, Inc. board of directors and serves on the compensation committee. Dr. Day earned his bachelor of science degree in biological psychology and his doctor of philosophy degree in neuroscience from Cardiff University. He completed his post doctorate studies in systems level neuroscience at The University of Edinburgh under Professor Richard G. Morris, FRS., FRSE.
This speaker's sessions: